ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AZN Astrazeneca Plc

12,018.00
-6.00 (-0.05%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.00 -0.05% 12,018.00 12,018.00 12,022.00 12,142.00 11,944.00 11,950.00 1,098,253 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.34 186.64B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,024p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,256.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £186.64 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.34.

Astrazeneca Share Discussion Threads

Showing 6101 to 6124 of 6150 messages
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older
DateSubjectAuthorDiscuss
04/3/2024
15:26
They bought one in early phase development in November:

hxxps://www.astrazeneca.com/media-centre/press-releases/2023/agreement-with-eccogene-for-clinical-stage-glp-1ra.html

andygibb101
01/3/2024
13:14
It's a shame Astra did not have the fat buster drug, Novo Nordisk and EJ Lily gone through the roof.
montyhedge
27/2/2024
08:15
Astra has an IR day in May where they are expected to try to talk up their longer term growth potential
smcni1968
21/2/2024
14:26
Money moving to APH , excellent growth health care company
blackhorse23
21/2/2024
10:55
philanderer - a suggestion
The link does work if you delete everything after "html" - otherwise it seems to stretch the page.

mirandaj
21/2/2024
00:19
"The £135m man: That's how much Pascal Soriot has been paid in 12 years at AstraZeneca... with more to come"
philanderer
20/2/2024
09:46
Berenberg cuts AstraZeneca price target to 12,000 (12,500) pence - 'buy'
philanderer
20/2/2024
00:23
MARKET REPORT: Lung cancer drug gives AstraZeneca a shot in arm
philanderer
19/2/2024
15:03
Hopefully the US investors will get this moving up tomorrow
smcni1968
19/2/2024
10:09
#987. Novo will need to use its new cash flows to diversify.
alphorn
19/2/2024
10:06
Today's news good for the company and good for patients.
alphorn
14/2/2024
09:04
Novo Nordisk the pharma to be in and Glaxo looking good.
montyhedge
12/2/2024
17:26
Market report

"...AstraZeneca shares came into the week on a three-day losing streak, including a more than 6% slide on the day it released annual results.

"‘We think this presents a compelling entry point for a best-in-class company,’ analysts at Barclays said on Monday, however."


sharesmagazine.co.uk

philanderer
12/2/2024
16:22
Don't tell me you sold these to buy APH as well! If APH are so good you should follow your own advice and put all your eggs in that creaky basket.
mattboxy
12/2/2024
16:13
Ex div on the 22nd, may pick up some before then.
chc15
12/2/2024
15:48
24 month low for the shareprice.

Chartwise, support at 8300p

philanderer
12/2/2024
11:50
Blackhorse. No it isn't. Grow up.
tday
12/2/2024
11:37
Money moving to APH
blackhorse23
12/2/2024
11:11
Quite a spread of views!

It is important to bear in mind what a commentator's price target means: it is not 'current fair value', but (unless otherwise stated) a price which the commentator at present believes will be hit at some time within the following 12 months, and not necessarily sustained thereafter, still less that there will not be further rises /falls from the price at the date on which the target was stated before that figure is hit, if indeed it is hit.

1knocker
12/2/2024
10:57
Stifel cuts AstraZeneca price target to 12,000 (12,550) pence - 'buy'

Barclays cuts AstraZeneca price target to 12,500 (13,500) pence - 'overweigh

UBS cuts AstraZeneca price target to 9,900 (10,700) pence - 'sell'

philanderer
09/2/2024
14:36
Deutsche Bank cuts AstraZeneca to 'sell' (hold) - price target 9,500 (11,000) pence
philanderer
08/2/2024
18:31
Rebounding in the US listing
smcni1968
08/2/2024
16:48
"Beckers2008 - 31 Mar 2022 - 14:48:08 - 5532 of 5974
I'm out at £102. This is above quite a few broker PT's so happy to take profits.
Currently way above 20 mda, too high too quickly, will buy back when it settles.
Good Luck all."

Should have held for a while longer, but you live and learn.

GLA.

beckers2008
08/2/2024
16:34
AZN is still pretty richly priced. I think it should slide a bit more. I may put a limit order in to buy a few more at 93, though that will significantly above my average, currently 58 after a few out and back in round trips a few years back.

AZN does not pay much of a dividend, and I see no catalyst to move the price north at present, so in this uncertain market I shall probably put in my order at 90 and be patient.

1knocker
Chat Pages: 246  245  244  243  242  241  240  239  238  237  236  235  Older

Your Recent History

Delayed Upgrade Clock